CF PharmTech, Inc. issued its monthly return for the period ended 31 January 2026. According to the announcement, the company’s registered share capital remained at 302,223,586 H shares and 109,754,801 Domestic Shares, both at a par value of RMB1, keeping the total at RMB 411,978,387.

The company disclosed that its issued H shares (excluding treasury shares) decreased by 102,000 to 302,054,586 during January, while the number of treasury shares increased by the equivalent amount from 67,000 to 169,000. The total number of H shares, at 302,223,586, remained unchanged. Meanwhile, the number of Domestic Shares stood at 109,754,801 with no movements. The public float stood in compliance with the applicable requirement of 24.7%. The monthly return was submitted on 05 February 2026.